Norge -
norsk -
Statens legemiddelverk
venlazid 150 mg
medical valley invest ab - venlafaksinhydroklorid - depottablett - 150 mg
Norge -
norsk -
Statens legemiddelverk
venlazid 75 mg
medical valley invest ab - venlafaksinhydroklorid - depottablett - 75 mg
Norge -
norsk -
Statens legemiddelverk
venlazid 225 mg
medical valley invest ab - venlafaksinhydroklorid - depottablett - 225 mg
Den europeiske union -
norsk -
EMA (European Medicines Agency)
pluvicto
novartis europharm limited - lutetium (177lu) vipivotide tetraxetan - prostatic neoplasmer, kastrering-resistant - terapeutisk radiofarmaka - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.
Norge -
norsk -
Statens legemiddelverk
venlix 37.5 mg
ratiopharm gmbh - venlafaksinhydroklorid - tablett - 37.5 mg
Norge -
norsk -
Statens legemiddelverk
efexor depot 150 mg
upjohn eesv - venlafaksinhydroklorid - depotkapsel, hard - 150 mg